相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
C. Michael Gibson et al.
AMERICAN HEART JOURNAL (2021)
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients
Bo Zheng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome
Alice Ossoli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity
Andreas Gille et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
C. Michael Gibson et al.
AMERICAN HEART JOURNAL (2019)
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function
Michael A. Tortorici et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
Andreas Gille et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction
Alexandre A. S. Soares et al.
CLINICA CHIMICA ACTA (2018)
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial A Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA CARDIOLOGY (2018)
Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction
Francesca Zimetti et al.
JOURNAL OF LIPID RESEARCH (2017)
High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
Chengfeng Qiu et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Serum amyloid A impairs the antiinflammatory properties of HDL
Chang Yeop Han et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
C. Michael Gibson et al.
CIRCULATION (2016)
Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity
Svetlana A. Didichenko et al.
CIRCULATION RESEARCH (2016)
Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease
Amit N. Vora et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2016)
ApoA-IMilano phospholipid complex (ETC-216) infusion in human volunteers. Insights into the phenotypic characteristics of ApoA-IMilano carriers
Charles L. Bisgaier et al.
PHARMACOLOGICAL RESEARCH (2016)
Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease
Amit N. Vora et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2016)
The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: The Modifying Orphan Disease Evaluation (MODE) study
G. Kees Hovingh et al.
AMERICAN HEART JOURNAL (2015)
HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export
Xian-Ming Du et al.
CIRCULATION RESEARCH (2015)
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial
Pierluigi Tricoci et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice
Bernd Hewing et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Mechanisms of Plaque Formation and Rupture
Jacob Fog Bentzon et al.
CIRCULATION RESEARCH (2014)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2014)
A Multiple Ascending Dose Study of CSL112, an Infused Formulation of ApoA-I
Rachael Easton et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Comprehensive plaque assessment by coronary CT angiography
Pal Maurovich-Horvat et al.
NATURE REVIEWS CARDIOLOGY (2014)
HDL-targeted therapies: progress, failures and future
Bronwyn A. Kingwell et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
Martin J. Landray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: Lack of compensation by LXRβ activation
Minako Ishibashi et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Foam cells in atherosclerosis
Xiao-Hua Yu et al.
CLINICA CHIMICA ACTA (2013)
Non-Fibroatheroma Lesion Phenotype and Long-Term Clinical Outcomes
Tomotaka Dohi et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Cholesterol Efflux and Atheroprotection Advancing the Concept of Reverse Cholesterol Transport
Robert S. Rosenson et al.
CIRCULATION (2012)
LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals
Christiane L. Haase et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort
Paul T. Williams et al.
ATHEROSCLEROSIS (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Anti-inflammatory effects of apolipoprotein A-I in the rabbit
Sanjay Patel et al.
ATHEROSCLEROSIS (2010)
The acute phase response inhibits reverse cholesterol transport
Kenneth R. Feingold et al.
JOURNAL OF LIPID RESEARCH (2010)
Inflammation Impairs Reverse Cholesterol Transport In Vivo
Fiona C. McGillicuddy et al.
CIRCULATION (2009)
The metabolism and anti-atherogenic properties of HDL
Kerry-Anne Rye et al.
JOURNAL OF LIPID RESEARCH (2009)
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
Daniel J. Rader et al.
JOURNAL OF LIPID RESEARCH (2009)
Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes
Sanjay Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo
Rajesh Puranik et al.
ATHEROSCLEROSIS (2008)
The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses
Giorgio Cavigiolio et al.
BIOCHEMISTRY (2008)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice
Yue Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-IMilano (ETC-216) administration -: Magnetic resonance imaging study in an experimental model of atherosclerosis
Borja Ibanez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
Xun Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Reconstituted HDL increases circulating endothelial progenitor cells in patients with type 2 diabetes
O. van Oostrom et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes
Sadako Motoyama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues
Salman Choudhary et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Nuclear factor κB signaling in atherogenesis
MPJ de Winther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
AC Newby
PHYSIOLOGICAL REVIEWS (2005)
High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation
RP Choudhury et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Rapid reversal of endothelial dysfunction in hypercholesterolemic apolipoprotein E-null mice by recombinant apolipoprotein A-IMilano-phospholipid complex
S Kaul et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids
C Vedhachalam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Matrix metalloproteinases: A review of their structure and role in acute coronary syndrome
CB Jones et al.
CARDIOVASCULAR RESEARCH (2003)
Recombinant apolipoprotein A-IMilano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks
G Chiesa et al.
CIRCULATION RESEARCH (2002)
High-dose recombinant apolipoprotein A-IMilano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice -: Potential implications for acute plaque stabilization
PK Shah et al.
CIRCULATION (2001)
Localization of human ATP-binding cassette transporter 1 (ABC1) in normal and atherosclerotic tissues
RM Lawn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Lessons from sudden coronary death - A comprehensive morphological classification scheme for atherosclerotic lesions
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase
MA Clay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
JJ Repa et al.
SCIENCE (2000)
分享论文
